Issue 2/2000
Content (8 Articles)
Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study
Giuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella, Renato Thomas, Immacolata Capasso, Maurizio Di Bonito, Flavia Rivellini, Giacomo Carteni, Luigi De Lucia, Luigi Maiorino, Roberta D'Aniello, Pasquale Frezza, Liliana Lapenta, Giuseppe Comella
Transcriptional suppression of synuclein γ (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M
Jingwen Liu, Michael J. Spence, Y. Lynda Zhang, Yangfu Jiang, Yiliang E. Liu, Y. Eric Shi
Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells
Ravi Patil, Jeffery B. Chavez, Douglas Yee
Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity
Jean-Jacques Michels, Françoise Duigou, Jacques Marnay
A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer
E. Esteban, González de Sande, J. Puertas, J. Fra, I. Palacio, J.M. Vieitez, J.L. Fernández, I. Muñiz, A. Modollel, J. Carrasco, M. Sala, A.J. Lacave
Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxel
M. Zambetti, G. Mariani, R. Demicheli, P. Verderio, P. Potepan, F. Garbagnati
Quality of life after adjuvant chemotherapy for breast cancer
Jo Ann Broeckel, Paul B. Jacobsen, Lodovico Balducci, John Horton, Gary H. Lyman
Characterization of a novel silencer element in the human aromatase gene PII promoter
Tianru Jin, Xiaoyun Zhang, Huiqin Li, Paul E. Goss